+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
From
From
From
From
From
Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Congestive Heart Failure (CHF) - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
Acute ischemic stroke (AIS) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acute ischemic stroke (AIS) - Epidemiology Forecast - 2032

  • Report
  • April 2023
  • 112 Pages
  • Global
From
Myocardial Infarction - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myocardial Infarction - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 110 Pages
  • Global
From
Lomitapide Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lomitapide Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more